Key result
Natakalim administered at 1 to /kg/day for 8 weeks improved hemodynamic parameters, such as reducing LVEDP, and prevented post-infarction left ventricular remodeling and cardiac failure in rats.
Why the study?
Does natakalim improve post-infarction left ventricular remodeling and prevent heart failure in a rat model of myocardial infarction?
Does natakalim improve post-infarction left ventricular remodeling and prevent heart failure in a rat model of myocardial infarction?
Natakalim prevents post-infarction hypertrophy and cardiac failure in rats by restoring the balance between endothelial function and cardiac hypertrophy.
Answers are grounded in this paper and cite their sources.
Does not support clinical use of natakalim post-MI; hypothesis-generating for translation from rat remodeling models.
Endothelial dysfunction can lead to congestive heart failure and the activation of endothelial ATP-sensitive potassium (K(ATP)) channels may contribute to endothelial protection. Therefore, the present study was carried out to investigate the hypothesis that natakalim, a novel K(ATP) channel opener, ameliorates post-infarction left ventricular remodeling and failure by correcting endothelial dysfunction. The effects of myocardial infarction were assessed 8 weeks following left anterior descending coronary artery occlusion in male Wistar rats. Depressed blood pressure, cardiac dysfunction, evidence of left ventricular remodeling and congestive heart failure were observed in the rats with myocardial infarction. Treatment with natakalim at daily oral doses of 1, 3 or 9 mg/kg/day for 8 weeks prevented these changes. Natakalim also prevented the progression to cardiac failure, which was demonstrated by the increase in right ventricular weight/body weight (RVW/BW) and relative lung weight, signs of cardiac dysfunction, as well as the overexpression of atrial and brain natriuretic peptide mRNAs. Our results also demonstrated that natakalim enhanced the downregulation of endothelium-derived nitric oxide, attenuated the upregulation of inducible nitric oxide synthase-derived nitric oxide (NO), inhibited the upregulated endothelin system and corrected the imbalance between prostacyclin and thromboxane A(2). Overall, our findings suggest that natakalim prevents post-infarction hypertrophy and cardiac failure by restoring the coordinated balance between endothelial function and cardiac hypertrophy.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2014) studied Myocardial infarction and left ventricular remodeling (n=69). Natakalim vs. Distilled water (MI model control) was evaluated on Left ventricular end diastolic pressure (LVEDP) in kPa (p=<0.01). Natakalim administered at 1 to /kg/day for 8 weeks improved hemodynamic parameters, such as reducing LVEDP, and prevented post-infarction left ventricular remodeling and cardiac failure in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: